ad image

Controlled Substances

1 / 1
Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market
CDMO

Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market

Tedor Pharma Services

PAO-08-23-CL-06Sep 26, 2023
Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand
Controlled Substances in Clinical Trials

Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand

Rich Nelson; John Hufnagel; Rachel Castro

PCI Pharma Services

PAO-01-23-CL-03Jan 30, 2023
1 / 1